Introduction
Primary Sj€ ogren's syndrome (pSS) is a female-dominant autoimmune disease with an obscure aetiology, which targets the exocrine glands [1] . Due to the strong female dominance and late onset of SS, usually coinciding with menopause and a decrease in sex steroid levels, we developed the hypothesis that sex steroids are central to the aetiology of SS. We have shown previously that patients with SS are androgen-depleted both systemically and locally in the salivary glands, a target tissue of SS, and suffer from endocrine and intracrine androgen defects [2] [3] [4] [5] .
Diagnosis of SS requires an indication of the autoimmune character of the disease in the form of either the presence of SS autoantibodies directed towards intracellular autoantigens such as Ro52, La or cleaved a-fodrin [6, 7] or the presence of lymphocyte infiltrates in labial salivary glands [8] . The inflammatory foci in the target glands consist of T and B lymphocytes, as well as macrophages and plasmacytoid dendritic cells (pDCs) [9] . pDCs are the main producers of type I interferons (IFNs) and act as antigen-presenting cells (APCs). They initiate an (auto)-immune response, but they also induce and maintain tolerance. Compared to conventional DCs, pDCs have high expression of endosomal Toll-like receptors (TLRs)-7 and 29, which sense single-stranded RNA or unmethylated cytosine-phosphate-guanine (CpG) DNA, respectively [10] [11] [12] . The nucleic acid stimulating the TLRs and activating pDCs can originate from either invading viruses and bacteria or in the context of autoimmune diseases, albeit of self-origin.
Immunocomplexes composed of autoantibodies, SSautoantigens and single-stranded hy1-RNA maintain the inflammatory environment in the target glands by activating local pDCs. This activation is initiated by adhesion of the immunocomplexes via autoantibodies to FcgRIIa receptors on the surface of pDCs followed by internalization of the complexes. This leads to stimulation of endosomal TLR-7 and -9 by hy1-RNA and secretion of IFN and/or proinflammatory cytokines, which aggravate the inflammation further. Additionally, activation of pDCs leads to processing and presentation of SS autoantigens to T cells and, further, to their priming [13, 14] .
Despite intensive research, the mechanisms leading to pDC stimulation and loss of immune tolerance in SS are still unknown. Apoptosis of the epithelial cells is increased in SS target glands [15, 16] . In apoptotic cells SS autoantigens are redistributed first to the cell surface and further to apoptotic membrane particles blebbing from the apoptotic cells [17, 18] . These particles, composed of smaller microparticles (200-1000 nm) emerging in early apoptosis and larger apoptotic bodies, appearing in later stages of the apoptosis, are carriers of cellular proteins and nucleic acids. Apoptotic particles have been associated with several inflammatory autoimmune diseases [19] .
We believe that defects in the production of sex steroids in SS salivary glands lead to increased apoptosis of the epithelial cells. Oestrogen deficiency has been shown to cause apoptosis of the submandibular gland serous epithelial cells and lead to an SS-like autoimmune exocrinopathy in female, but not male, mice [20, 21] . We thus hypothesized that androgens could protect from the oestrogen depletion-induced apoptosis that could explain the strong female dominance of SS. We propose that apoptotic particles derived from the apoptotic salivary gland cells transfer SS autoantigens and single-stranded nucleic acids, such as hy1-RNA, to local pDCs in SS salivary glands. This enables autoantigens and nucleic acids to reach and activate pDCs via endosomal TLRs. Activated pDCs secrete type I IFN and/or proinflammatory cytokines, which may further activate salivary gland epithelial cells and/or immune cells to perpetuate SS inflammation. Thus, androgen depletion in SS not only predisposes salivary gland cells to apoptosis, but also has later affects during pDC-related stages of the disease, when secretion of IFN-a leads to amplification of local injury in salivary glands and activation of lymphocytes to promote systemic inflammation. According to our hypothesis, the particle-mediated activation of pDCs may affect immune tolerance in SS [22] . In this study we explore further the role of apoptotic particles and pDCmediated autoimmune responses by analysing in-vitro effects of apoptotic particles from epithelial cells on pDCs in a hormone-supplemented/depleted environment.
Materials and methods

Cell cultures
HSG cells used in this study for the production of apoptotic particles were thought originally to be established from a human submandibular gland [23] , but were found to be indistinguishable from the HeLa epithelial cell line by shorttandem repeat polymerase chain reaction (STR PCR) DNA profiling, and are therefore currently deposited in Sigma cat. no. 95031024 (St Louis, MO, USA) as HSG (HeLa derivative). Cells were cultured in RPMI-1640 (GIBCO BRL, Grand Island, NY, USA) supplemented with 10% fetal calf serum (FCS), L-glutamine and antibiotics. Apoptosis was induced with 10 ng/ml tumour necrosis factor (TNF; R&D Systems, Minneapolis, MN, USA) and 10 mg/ml cycloheximide (CHX; Sigma) for 4 h [24] . Live cells and apoptotic blebs were visualized with CellTrace green dye (Molecular Probes, Leiden, the Netherlands) and live and dead cells with the live/dead kit for mammalian cells (Invitrogen, San Diego, CA, USA). Cells cultured on coverslips and treated with apoptotic agents with or without sex steroids were stained according to the manufacturer's instructions and observed with a fluorescence microscope. Living cells and the ratio of live/dead cells were counted by segmenting, using the maximum entropy-based thresholding and watershed-algorithm (Image J; National Institutes of Health, Bethesda, MD, USA). Apoptosis was also detected by annexin V staining with a polyclonal goat antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and fluorescein isothiocyanate (FITC)-conjugated donkey anti-goat immunoglobulin (Ig)G as a secondary antibody (Molecular Probes) blocked with 10% donkey normal serum (Dako, Glostrup, Denmark). Propidium iodide was used as a nuclear stain, while control cells were permeabilized with 0Á5% Triton X-100.
A human pDC cell line GEN2. 
Patients and samples
Serum and saliva samples were collected for a-fodrin measurement, as described previously [3, 26] , from patients with pSS (n 5 13, aged 44-70 years, average 56 years) before and after dehydroepiandrosterone (DHEA) replacement therapy [27] and from healthy controls (n 5 13, aged 23-51 years, average 37 years). a-Fodrin was measured with enzyme-linked immunosorbent assay (ELISA) (USCN Life Science, Inc., Wuhan, China).
Isolation of apoptotic microparticles
After apoptosis induction in epithelial cell cultures, particles were collected by five consecutive centrifugations of the culture media at different speeds: first, at 89 g for 10 min yielded pellet 1; secondly, pellet 2 at 357 g for 10 min; thirdly, pellet 3 at 1400 g for 10 min; fourthly, pellet 4 at 16 000 g for 120 min; and finally, pellet 5 at 100 000 g for 1 h. For flow cytometry, 200 ml of phosphate-buffered saline (PBS) was added to pellets and the samples were analysed with fluorescence activated cell sorter (FACS)Aria (BD Biosciences, San Jose, CA, USA). Gates were set for 1 and 4 mm with control latex fluorescence (FITC) beads (L4655; Sigma) and FACSAria control beads (Supporting information, Fig. S1 ). Epithelial cells were labelled fluorescently with CellTrace TM carboxyfluorescein succinimidyl ester (CFSE) (Molecular Probes/Life Technologies, Grand Island, NY, USA) for flow cytometry, electron microscopy and cytochemistry analyses. For imaging, 100 ml of suspended pellets were cytospinned and particles/cells were analysed using a Leica DM6000 microscope (Leica Microsystems, Wetzlar, Germany) and Leica TCS SP2 AOBS laser scanning confocal microscope (Leica Microsystems). pDCs were stained with HCS CellMask Blue (Molecular Probes) for cytoplasm and To-PRO-3 (Molecular Probes) for nuclei.
To quantify microparticles with flow cytometry, events in the size range of 0Á1-1Á0 mm particle diameter were gated and recorded during a 60-s running time. Results were expressed as relative number of microparticles in relation to particles from untreated cells. For autoantigen expression within the apoptotic bodies and microparticles, they were fixed and permeabilized with 0Á25% saponin. Cleaved a-fodrin was detected with a polyclonal rabbit antibody (Cell Signaling, Danvers, MA, USA) specific for the 150-kD amino terminal cleavage product of human a-fodrin (Asp 1185) and AlexaFluor FITCconjugated donkey anti-rabbit IgG as a secondary antibody (Molecular Probes, Leiden, the Netherlands). SSA/ Ro 52 was detected using a reference human serum (with SSA/Ro52 reactivity, Centers for Disease Control Atlanta, GA, USA) and FITC-conjugated anti-human IgG (Nova Diagnostics Inc., Brooklyn, NY, USA) Stimulation of pDC pDCs were stimulated with isolated apoptotic particles for 18 h. Pellets 3-5 were suspended with 500 ml of cell culture media (RPMI-1640; GIBCO BRL) and 100 ml was used for stimulation pDCs cultured at 8 3 10
5 cells/ml in a 96-well plate. TLR-7 ligand (Imiquimod-R837; InvivoGen, San Diego, CA, USA) was used as positive and negative control without apoptotic particles. The effect of hormones on pDC activation was tested by adding dihydrotestosterone (DHT; 1, 10, 100 nM) or 17-b-oestradiol (E2; 0Á1, 1, 10 nM) 24 h prior to stimulation.
Quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from pDC using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Complementary firststrand DNA (cDNA) was synthesized from 100 ng of total RNA in 20 ml with iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). Expression of TLR-7 and -9 in stimulated pDCs and type I IFNs in TLR-7 ligand-and particle-stimulated pDCs was studied with quantitative iQ5 real-time PCR detection system (Bio-Rad) containing 2 ml of cDNA and 250 nM of each primer (Table 1) . Relative expression was analysed using the DDCt method.
Immunofluorescence staining
Staining of a-fodrin was performed with antibody recognizing only the cleaved form of a-fodrin (Cell Signaling). Cells grown on coverslips, treated with apoptotic inducers with or without sex steroids, were permeabilized with 0Á5% Triton X-100, blocked with 10% goat normal serum (Dako) and incubated in the primary antibody diluted 1 : 100 overnight in 148C. Rabbit IgG was used as negative control. Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) (Sigma).
Western blot
The pellets of apoptotic particles were suspended in lysis buffer [10 mM Tris, 150 mM NaCl, ethylenediamine tetraacetic acid (EDTA) 7 mM, 0Á5% NP-40, pH 7.7] supplemented with 1 mM phenylmethane sulphonyl fluoride TLR-7  NM_016562  ATGCTCTGCTCTCTTCAACC  TGGTTAATGGTGAGGGTGAG  TLR-9  NM_017442  TGTTGTCCTACAACCGCATC  TCAACACCAGGCCTTCAAGA  IFN-a2  NM_000605  TTCGTATGCCAGCTCACCTT  ATCAGTCAGCATGGTCCTCTG  IFN-b1  NM_002176  GAGCTACAACTTGCTTGGATTCC  CAAGCCTCCCATTCAATTGC  hy1-RNA  NR_004391  GGCTGGTCCGAAGGTAGTGA  GCAGTAGTGAGAAGGGGGGA  RPLP0  NM_001002/NM_053275  CCATCAGCACCACAGCCTTC  GGCGACCTGGAAGTCCAACT  HPRT  NM_000194  AGATCCATTCCTATGACT  CATCTCCACCAATTACTT qRT-PCR 5 quantitative polymerase chain reaction; TLR 5 Toll-like receptor; IFN 5 interferon; RPLP0 5 ribosomal protein lateral stalk subunit P0; HPRT 5 hypoxanthine-guanine phosphoribosyltransferase.
Dendritic cell activation by cell apoptosis (PMSF) and 1/100 aprotinin. Cells treated with TNF and CHX were used as positive controls. Samples were incubated for 15 min on ice in lysis buffer and heated for 8 min at 1708C in sample buffer (Invitrogen). Protein electrophoresis was performed using 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (NuPAGE; Invitrogen). For Western blot, membranes were incubated with primary antibodies (cleaved a-fodrin, SSA/ Ro52; see above) overnight at 148C, with horseradish peroxidase (HRP)-conjugated secondary antibody for 1 h at room temperature (RT) and finally in chemiluminescence substrate solution (GE Healthcare, Amersham, UK).
Analysis of pDC cytokine profiles
The effect of apoptotic particles on cytokine secretion by pDCs was assessed with the xMAP kit (MPXHCYTO-60K; Millipore) using the Bio-Plex 200 system (Bio-Rad). To measure the effect of 17-b-oestradiol and DHT on the pDC cytokine profile, the cytokines that were most affected by apoptotic particles [interleukin (IL)-4, IL-6, IL-8, TNF and IL-10] were also quantified with the fluorokine multianalyte profiling (MAP) kit (R&D Systems, Minneapolis, MN, USA) after hormone stimulation. The production of type I IFN-a in TLR-7 ligand-and particle-stimulated pDCs was also verified with the Verikine human IFN-a ELISA kit (PBL Assay Science, Piscataway, NJ, USA).
Statistical analysis
Relative proportions of live/dead cells after apoptotic 6 hormone stimulations were compared using the MannWhitney U-test. Overall effects of stimulations with different concentrations of sex steroids were studied using the Kruskall-Wallis test. The levels of a-fodrin in serum and saliva, the amount of microparticles and hy1-RNA expression were compared with the Mann-Whitney test. qPCR data were analysed using one-way analysis of variance (ANOVA) with Tukey's post-hoc test. Data in figures are presented as mean 6 standard error of the mean (s.e.m.). The level of significance was set at 0Á05.
Results
Induction and isolation of apoptotic particles in epithelial cells by TNF and cycloheximide
Treatment with 10 ng/ml TNF and 10 mg/ml CHX for 4 h, which induces extrinsic apoptosis [22] , decreased the proportion of living cells (from 87Á4 to 11Á9%; P < 0Á001; Fig.  1a ) and almost doubled the secretion of apoptotic particles compared with untreated cells (P < 0Á001; n 5 12, Fig. 1b) . Cell death was shown to be due to apoptosis, as shown by positive annexin V staining (Fig. 1c) . During the first steps of isolation apoptotic particles were separated from cells and cell debris in pellets 1 and 2. Apoptotic bodies (1-4 mm) and microparticles (200-1000 nm) were collected during the next centrifugation steps. Exact separation of apoptotic bodies and microparticles was not feasible, because their sizes overlapped partially. In pellet 3 there were more apoptotic bodies, while there were more microparticles in pellet 5. Pellet 4 contained equal amounts of both (Supporting information, Fig. S2 ).
Apoptosis induces the secretion of apoptotic particles and leads to processing of SS autoantigens and the presence of hy1-RNA in apoptotic particles
Apoptotic treatment with 10 ng/ml TNF and 10 mg/ml CHX was associated with increased cleavage of SS autoantigen a-fodrin (Fig. 2a) . Single-stranded hy1-RNA, which is part of the RNP complexes, together with SS autoantigens Ro and La, was detected in cell-derived apoptotic particles (n 5 12, Fig. 2b ). Apoptotic particles contained SS autoantigen-cleaved a-fodrin and SSA/Ro52, as shown by flow cytometry (n 5 12). SSA/Ro52 was increased significantly by TNF/CHX and was localized both on the surface and inside the particles (Fig. 2c) . Conversely, the differences of cleaved a-fodrin was found in cell-derived particles only after the TNF/CHX stimulation and was found only inside the particles (Fig. 2c) .
Expression of TLRs and the secretion of cytokines after pDC stimulation with apoptotic particles
Apoptotic particles were attached to or taken into pDCs (Fig. 3a) . The intake of fraction P4 increased the expression of endosomal TLR-9 (P 5 0Á035) and P5 TLR-7 (P 5 0Á013, n 5 4, Fig. 3b ). The TLR-7 ligand induced pDC maturation, as determined by the induction of IFNs, while particle fractions showed a slight or no increase (Fig. 3c) . Stimulation of pDCs with apoptotic particles had a clear effect on the secretion of proinflammatory cytokines by pDCs. The most increased cytokines were TNF (95Á2 and 1465Á6 pg/ml, before and after P5 stimulation, respectively, n 5 4) and IL-8 (1Á4 and 2366Á1 pg/ml) (Fig. 3d) . The production of anti-inflammatory cytokines (IL-4, IL-10) was either non-detectable or very weak (data not shown).
Effect of sex steroids on pDC cytokine profile and TLR expression
DHT and pretreatments decreased apoptotic particle fraction P4-induced expression of TLR-9 in pDCs (P 5 0Á049; n 5 4, Fig. 4 ), but had no effect on P4-induced expression on TLR-7. DHT and E2 had no significant effect on P3-and P5-induced TLR expression. Pretreatment with either DHT or E2 did not affect the production of proinflammatory TNF, IL-6 or IL-8 or anti-inflammatory IL-4 and IL-10. Effect of androgens on epithelial cells apoptosis and cleavage of a-fodrin DHT decreased epithelial cell apoptosis induced by TNF and CHX (Fig. 5a-c) . Pretreatment of cells with different concentrations of DHT prior to 10 ng/ml TNF and 10 lg/ ml CHX treatment increased the proportion of living cells compared to cells with no hormonal pretreatment (P 5 0Á017; n 5 12). Individual effects of DHT concentrations were as follows: pretreatment with 0Á5 nM DHT increased the proportion of living cells from 11Á9 to 25Á8% (P 5 0Á018), 10 nM DHT to 26Á6% (P 5 0Á004), 100 nM DHT to 20% (P 5 0Á009) and 1 mM DHT to 23Á4% (P 5 0Á01). One mM DHEA also increased the proportion of living cells (from 13Á7 to 22Á4%) observed after apoptosis induction, but the difference was not significant (P 5 0Á091). a-Fodrin cleavage was protected with 1 mM DHEA and higher concentrations of DHT (10, 100 and 1000 nM), but not 0Á5 nM (Fig. 5d-g ); 17-b-oestradiol had no effect on apoptosis or a-fodrin cleavage of TNF/CHXtreated cells.
SS autoantigen a-fodrin in saliva and serum of pSS patients
The amount of a-fodrin in serum did not differ significantly between healthy controls and pSS patients (11Á38 6 1Á02 ng/ml versus 10Á95 6 0Á51 ng/ml, respectively; n 5 13). Additionally, DHEA treatment did not affect serum levels of a-fodrin in pSS patients Fig. 3 . The intake of apoptotic particles increased Toll-like receptors (TLRs) and proinflammatory cytokines in plasmacytoid dendritic cells (pDCs). Cell-derived apoptotic particles were attached to the surface or taken into pDCs (a). Expression of endosomal TLR-7 and -9 (b, n 5 4), interferon (IFN)-a2 and IFN-b1 (c, n 5 3) and production of proinflammatory cytokines (d, n 5 4) in pDCs. *P < 0Á05; ****P < 0Á0001; panel (c) versus TLR-7 ligand-induced stimulation. Scale bar 20 mm. Red: nuclear stain, blue: cytoplasm, green: apoptotic particles. Fig. 4 . Androgen effects on Toll-like receptor (TLR) expression in plasmacytoid dendritic cells (pDCs). Dihydrotestosterone (DHT) pretreatment resulted in decrease of TLR-9 and increase of TLR-7 expression in pDCs (n 5 3). P4: fraction of apoptotic particles, E 2 : oestradiol. *P < 0Á05; **P < 0Á01 versus control;
(10Á95 6 0Á51 ng/ml versus 11Á33 6 0Á55 ng/ml before and after DHEA treatment, respectively) (data not shown). However, salivary a-fodrin was higher in patients with SS compared to healthy controls (2Á0 6 0Á49 ng/ml versus 0Á929 6 0Á24 ng/ml, respectively; P < 0Á05, n 5 13). DHEA treatment caused a decrease of salivary a-fodrin levels, but this change did not reach statistical significance in our group of patients (2Á0 6 0Á49 ng/ml versus 1Á66 6 0Á31 ng/ ml before and after DHEA treatment, respectively; Fig. 6 ).
Discussion
The factors causing the loss of immune tolerance and onset of pSS are still obscure. We postulated that epithelial cell apoptosis and the following pDC activation cause the breakdown of immune tolerance in pSS patients. As SSrelated autoimmune processes affect women so discriminatingly and not men, we hypothesized that hormonal imbalance is the fundamental cause of the increased apoptosis associated with autoimmune inflammation in the SS target glands. Although, in this study, we have focused upon hormonal aspects, genetic and environmental factors also influence the development of SS [7, 28] . We tested our hypothesis by studying the role of apoptosisrelated events on the activation of pDCs and onset of autoimmunity in salivary glands. We also evaluated the effect of sex steroids in these processes.
Apoptosis plays a role in normal tissue homeostasis as well as during embryogenesis. However, apoptosis participates in the pathogenic processes of many diseases, of which SS is an example [16] . In this study we showed that apoptosis of the epithelial cells leads to the processing and redistribution of SS autoantigens a-fodrin and SS-A (Ro) to cell surface blebs. We found that the effects of apoptotic particles depend upon their size. Differential localization of autoantigens, either on the surface or inside the particles, may also affect separate pathways in target cells: smaller particles binding receptors inside and larger particles outside on the surface of the cells. Future study of the content of different fractions may identify new markers and potential different pathways associated with different populations of apoptotic particles in autoimmunity. Here, current observations supported our hypothesis, according to which these particles carry SS autoantigens, and demonstrated that these apoptotic particles are attached to or taken into pDCs. Accordingly, epithelial cell-derived apoptotic particles can carry SS-autoantigens to local pDCs located in SS salivary glands, and consequently pDCs can be activated by autoantigens in SS.
Once inside the pDCs, hy1-RNA can activate the cells via TLR-7 or TLR-9. We showed that the stimulation of pDCs with apoptotic particles leads to increased expression of both TLR-7 and TLR-9. Additionally, we showed that apoptotic particles also carry self-hy1-RNA, which is a ligand for TLR-7. We also demonstrated that the TLRmediated activation of pDCs results in increased secretion of proinflammatory cytokines TNF and IL-8. Interestingly, intake of apoptotic particles only slightly induced the production of type I IFN in pDCs. However, this was predictable, as the stimulation of pDCs via TLR agonists has been shown to lead to either IFN regulatory factor 7 (IRF7)-mediated type I IFN production or nuclear factor kappa B (NF-jB)-mediated production of proinflammatory cytokines and maturation into antigen-presenting cells. TLR ligands targeted to early endosomes lead to type I IFNs production, whereas TLR ligands that localize in the late endosomes lead to maturation of pDCs and production of proinflammatory cytokines [29] [30] [31] . Thus, our results suggest that cell-derived apoptotic particles activate TLRs in late rather than early endosomes.
Cytokines produced by pDCs can direct the differentiation of T lymphocytes into different T helper (Th) subsets. IL-12 and type I IFNs promote the synthesis of Th1 cells and may take part in the autoimmune processes [32] . Th2 cells, involved in allergic responses and asthma, are produced in the presence of IL-4. However, the maturation of pDCs following particle stimulation enables pDCs to express proinflammatory cytokines TNF and IL-8. In SS, pDCs are present in salivary glands and may thus contribute to local inflammation [33] . Increase of TNF and IL-6 cytokines was observed earlier in patients with pSS on systemic and/or salivary gland levels. Systemic levels of IL-8 were demonstrated to be decreased significantly in pSS [34, 35] , while in our study IL-8 increased in the apoptotic environment of pDC. Apoptotic particles may induce autoimmunity by expressing autoantigens and initiate autoantibody production although, in SS, the production of autoantibodies may appear years before the onset of SS and, thus, before menopause [36] . It has been shown that autoantibodies from SS patients trigger apoptosis [37] . Consequently, the increased production of apoptotic particles after menopause may play a role in maintaining and perpetuating the production of autoantibodies and inflammation leading to the clinical manifestation of SS.
We have demonstrated that androgens reduce apoptosis and a-fodrin cleavage in epithelial cells, which could explain the epithelial cell destruction in SS salivary glands in which only limited amounts of androgens are available. At the patient level, we demonstrated higher levels of afodrin in SS saliva, but not in serum, in DHEA-deficient pSS patients. Local defects in the synthesis of the most active androgen DHT from DHEA in SS salivary glands [4, 5] could explain why oral DHEA treatment did not decrease the a-fodrin levels significantly in SS saliva. We showed that androgens also affect pDC by decreasing TLR-9 expression in pDCs stimulated with apoptotic particles. In women, who do not have testicle-derived testosterone in their circulation, the local intracrine synthesis of androgens is essential, especially after the menopause. When both systemic DHEA production and local DHT synthesis are defective, as is the case in pSS salivary glands [4, 5] , patients suffer from local androgen depletion. Accordingly, androgen impediments seen in SS can predispose women to apoptosis, pDC activation and finally to loss of immunological tolerance.
The present study has some limitations. The study was started with the primary idea of using an HSG cell line as a model for salivary gland epithelial cells. Unfortunately, this cell line was found afterwards to be contaminated with HeLa cells at an earlier stage. However, the cell line was then used in this study only as a source for apoptotic particles. A pDC cell line was also used instead of primary cells, as concentration in peripheral blood is only < 0Á4%, and thus it was not possible to acquire enough primary Fig. 6 . Autoantigen a-fodrin is increased in saliva of Sj€ ogren's syndrome (SS) patients. SS patients have higher amounts of a-fodrin in saliva than the control group. Salivary a-fodrin decreased after dehydroepiandrosterone (DHEA) treatment, but the change was not statistically significant in this group (n 5 13). *P < 0Á05 versus control.
cells for this study. Further studies with salivary gland cells and primary pDCs are needed to confirm our results.
In conclusion, we have demonstrated that apoptosis of the epithelial cells leads to the redistribution of SS autoantigens, including hy1-RNA, to apoptotic particles blebbing from the apoptotic cells. These particles carry autoantigens and adjuvant nucleic acid to pDCs found in local infiltrates in pSS salivary glands. pDCs are stimulated via TLR-7 and -9 by the nucleic acid to mature and produce proinflammatory cytokines, enabling the activation of autoreactive T and B cells. We found that the effects of apoptotic particles on TLR expression and cytokine production depend upon the particle size. These events could explain how immune tolerance is broken in SS. Androgens protect epithelial cells from apoptosis and the redistribution of autoantigens and prevent the up-regulation of TLR-9 in particle-stimulated pDCs. Thus, androgen defects during menopause, caused by systemic androgen depletion and defective local DHT production in SS salivary glands, might enhance salivary gland cell apoptosis, the presentation of danger signals and potential autoantigens resulting in pDC activation, which might lead to the loss of immune tolerance, the production of autoantibodies and the onset of autoinflammation.
